+86 0731-89837621

EN
Alle Produkte

Pharmazeutisches Zwischenprodukt

KONTAKT

Telefon:+86 0731-89837621

Email:[E-Mail geschützt]

Adresse: 1288 Purui West Road, Wangcheng wirtschaftliche und technologische Entwicklungszone, Stadt Changsha, Provinz Hunan, China

  • https://www.hnnanbeiwang.com/upload/product/1611654492940473.png

(R)-(-)-2-Chloromandelicacid

(R)-(-)-2-Chloromandelicacid can synthesize a new safe and effective antiplatelet aggregation drug clopidogrel.The chemical name of clopidogrel is (+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-methyl acetate, Clinically used to prevent myocardial infarction, stroke or atherosclerosis in patients with a history of peripheral arterial disease, Compared with several other widely used platelet inhibitors (aspirin, ticlopidine, etc.), the intensity of action and tolerability are higher than that of ticlopidine, and the overall tolerance is similar to that of aspirin, and the side effects are also smaller than other platelet inhibitors.

Anfrage
  • BESCHREIBUNG

(R)-(-)-2-Chloromandelicacid can synthesize a new safe and effective antiplatelet aggregation drug clopidogrel.The chemical name of clopidogrel is (+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-methyl acetate, Clinically used to prevent myocardial infarction, stroke or atherosclerosis in patients with a history of peripheral arterial disease, Compared with several other widely used platelet inhibitors (aspirin, ticlopidine, etc.), the intensity of action and tolerability are higher than that of ticlopidine, and the overall tolerance is similar to that of aspirin, and the side effects are also smaller than other platelet inhibitors.

Herkunftsort:

China

Markenname:

Hunan Nanbeiwang Biologische Technologie Co., Ltd.

Modellnummer:

26

 

Produkt Chinesisch Name:

R-(-)-邻氯扁桃酸

Produkt Englisch Name:

(R)-(-)-2-Chloromandelicacid

CAS:

52950-18-2

Molekular- FOrmula:

C8H7ClO3

Molekular- Wacht:

186.59

Anwendungen:

Pharmaceutical intermediates, clopidogrel intermediates

Kontakt